TriMas (NASDAQ:TRS) Sets New 52-Week Low at $22.45

Shares of TriMas Co. (NASDAQ:TRS) reached a new 52-week low on Monday . The company traded as low as $22.45 and last traded at $22.70, with a volume of 29862 shares. The stock had previously closed at $23.76.

Analyst Ratings Changes

Separately, BWS Financial reaffirmed a “buy” rating and set a $40.00 target price on shares of TriMas in a report on Wednesday, July 31st.

TriMas Stock Performance

The company has a market cap of $944.60 million, a P/E ratio of 23.91 and a beta of 0.67. The stock has a 50 day moving average price of $25.83 and a two-hundred day moving average price of $25.74. The company has a quick ratio of 1.41, a current ratio of 2.82 and a debt-to-equity ratio of 0.63.

TriMas (NASDAQ:TRS) last posted its quarterly earnings data on Tuesday, July 30th. The industrial products company reported $0.43 earnings per share for the quarter, missing the consensus estimate of $0.53 by ($0.10). TriMas had a return on equity of 9.61% and a net margin of 4.44%. The firm had revenue of $240.50 million for the quarter, compared to the consensus estimate of $238.63 million. During the same quarter in the previous year, the business earned $0.50 EPS. The firm’s quarterly revenue was up 3.1% on a year-over-year basis. On average, research analysts predict that TriMas Co. will post 1.72 earnings per share for the current fiscal year.

TriMas Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Tuesday, August 13th. Investors of record on Tuesday, August 6th will be paid a $0.04 dividend. This represents a $0.16 dividend on an annualized basis and a yield of 0.69%. The ex-dividend date is Tuesday, August 6th. TriMas’s dividend payout ratio (DPR) is presently 16.49%.

Insider Buying and Selling at TriMas

In other TriMas news, CFO Scott A. Mell sold 1,500 shares of the firm’s stock in a transaction on Tuesday, May 21st. The stock was sold at an average price of $27.30, for a total value of $40,950.00. Following the sale, the chief financial officer now owns 31,923 shares of the company’s stock, valued at approximately $871,497.90. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. Insiders own 1.10% of the company’s stock.

Institutional Inflows and Outflows

A number of large investors have recently modified their holdings of the company. Innealta Capital LLC bought a new position in TriMas in the second quarter valued at about $26,000. SG Americas Securities LLC acquired a new position in TriMas in the 4th quarter valued at approximately $205,000. Quantbot Technologies LP raised its stake in shares of TriMas by 5.7% during the first quarter. Quantbot Technologies LP now owns 8,933 shares of the industrial products company’s stock valued at $239,000 after acquiring an additional 478 shares during the last quarter. Handelsbanken Fonder AB lifted its holdings in shares of TriMas by 19.8% during the fourth quarter. Handelsbanken Fonder AB now owns 15,095 shares of the industrial products company’s stock worth $382,000 after purchasing an additional 2,500 shares during the period. Finally, Summit Trail Advisors LLC grew its stake in shares of TriMas by 5.0% in the fourth quarter. Summit Trail Advisors LLC now owns 15,158 shares of the industrial products company’s stock worth $384,000 after purchasing an additional 716 shares during the last quarter. 99.42% of the stock is currently owned by institutional investors.

About TriMas

TriMas Corporation engages in the design, development, manufacture, and sale of products for consumer products, aerospace, and industrial markets worldwide. The company operates through Packaging, Aerospace, and Specialty Products segments. The Packaging segment offers dispensing products, such as foaming and sanitizer pumps, lotion and hand soap pumps, beverage dispensers, perfume sprayers, and nasal and trigger sprayers; polymeric and steel caps and closures comprising food lids, flip-top and beverage closures, child resistance caps, drum and pail closures, and flexible spouts; polymeric jar products; integrated dispensers; bag-in-box products; and consumable vascular delivery and diagnostic test components under the Rieke, Taplast, Affaba & Ferrari, Intertech, Omega, and Rapak brands.